# SHR0302 and Steroid As First Line Therapy for Chronic GVHD

> **NCT04146207** · EARLY_PHASE1 · COMPLETED · sponsor: **Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine** · enrollment: 28 (actual)

## Conditions studied

- Chronic GVHD

## Interventions

- **DRUG:** SHR0302
- **DRUG:** Prednisone

## Key facts

- **NCT ID:** NCT04146207
- **Lead sponsor:** Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-04-02
- **Primary completion:** 2024-09-30
- **Final completion:** 2024-10-31
- **Target enrollment:** 28 (ACTUAL)
- **Last updated:** 2024-11-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04146207

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04146207, "SHR0302 and Steroid As First Line Therapy for Chronic GVHD". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04146207. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*